James E. Weiel

2.1k total citations
28 papers, 1.8k citations indexed

About

James E. Weiel is a scholar working on Molecular Biology, Rheumatology and Infectious Diseases. According to data from OpenAlex, James E. Weiel has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Rheumatology and 4 papers in Infectious Diseases. Recurrent topics in James E. Weiel's work include Glycogen Storage Diseases and Myoclonus (4 papers), HIV Research and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). James E. Weiel is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (4 papers), HIV Research and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). James E. Weiel collaborates with scholars based in United States, Netherlands and United Kingdom. James E. Weiel's co-authors include E G Krebs, Thomas A. Hamilton, Dolph O. Adams, Natalie G. Ahn, C. P. Chan, James M. Lenhard, Mark Paulik, Edmond H. Fischer, Scott D. Somers and Eric S. Furfine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

James E. Weiel

28 papers receiving 1.7k citations

Peers

Countries citing papers authored by James E. Weiel

Since Specialization

Citations

This map shows the geographic impact of James E. Weiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Weiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Weiel more than expected).

Fields of papers citing papers by James E. Weiel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Weiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Weiel. The network helps show where James E. Weiel may publish in the future.

Co-authorship network of co-authors of James E. Weiel

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Weiel. A scholar is included among the top collaborators of James E. Weiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Weiel. James E. Weiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Karen A. Evans, (unknown), Frank T. Coppo, Todd L. Graybill, (unknown), Mehul Patel, Jennifer Gale, Hu Li, Sara H. Thrall, David G. Tew, Francis X. Tavares, Stephen A. Thomson, James E. Weiel, Joyce A. Boucheron, (unknown), Andrea H. Epperly, Pamela L. Golden	9
2	Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups 2008 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Sparks, (unknown), D. Mark Bickett, H. Luke Carter, (unknown), Scott H. Dickerson, (unknown), Dulce Garrido, Pamela L. Golden, Robert T. Nolte, Andrew J. Peat, (unknown), Francis X. Tavares, Stephen A. Thomson, Liping Wang, James E. Weiel	6
3	Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy 2008 ·Bioorganic & Medicinal Chemistry Letters ·Stephen A. Thomson, (unknown), D. Mark Bickett, Joyce A. Boucheron, (unknown), (unknown), Joel P. Cooper, Scott H. Dickerson, Dulce Garrido, Robert T. Nolte, Andrew J. Peat, (unknown), Steven M. Sparks, Francis X. Tavares, Liping Wang, (unknown), James E. Weiel	16
4	Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues 2008 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Sparks, (unknown), D. Mark Bickett, (unknown), Scott H. Dickerson, Dulce Garrido, Pamela L. Golden, Andrew J. Peat, (unknown), Francis X. Tavares, Stephen A. Thomson, James E. Weiel	5
5	HIV protease inhibitors block adipogenesis and increase lipolysis in vitro 2000 ·Antiviral Research ·James M. Lenhard, Eric S. Furfine, Renu Jain, Olivia Ittoop, Lisa A. Orband‐Miller, Steven G. Blanchard, Mark Paulik, James E. Weiel	135
6	Dietary Fat Alters HIV Protease Inhibitor–Induced Metabolic Changes in Mice 2000 ·Journal of Nutrition ·(unknown), Dallas K. Croom, James E. Weiel, Andrew Spaltenstein, David J. Reynolds, Eric S. Furfine	23
7	Stimulation of vitamin A1 acid signaling by the HIV protease inhibitor indinavir 2000 ·Biochemical Pharmacology ·(unknown), James E. Weiel, Mark Paulik, Eric S. Furfine	54
8	HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis 2000 ·Arteriosclerosis Thrombosis and Vascular Biology ·James M. Lenhard, Dallas K. Croom, James E. Weiel, Deborah A. Winegar	106
9	The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction 1999 ·Diabetologia ·James M. Lenhard, Mary E. Lancaster, Mark Paulik, James E. Weiel, Jane G. Binz, Scott S. Sundseth, (unknown), Ruth M. Lightfoot, H. Roger Brown	78
10	Development of Infrared Imaging to Measure Thermogenesis in Cell Culture: Thermogenic Effects of Uncoupling Protein-2, Troglitazone, and β-Adrenoceptor Agonists 1998 ·Pharmaceutical Research ·Mark Paulik, Richard G. Buckholz, Mary E. Lancaster, (unknown), Emily A. Hull-Ryde, James E. Weiel, James M. Lenhard	74
11	Effects of troglitazone and metformin on glucose and lipid metabolism 1997 ·Biochemical Pharmacology ·James M. Lenhard, Steven A. Kliewer, Mark Paulik, Kelli D. Plunket, Jürgen M. Lehmann, James E. Weiel	91
12	Okadaic acid mimics the action of insulin in stimulating protein kinase activity in isolated adipocytes. The role of protein phosphatase 2a in attenuation of the signal. 1990 ·Journal of Biological Chemistry ·Timothy Haystead, James E. Weiel, David W. Litchfield, Yasumasa Tsukitani, Edmond H. Fischer, E G Krebs	173
13	Regulation of S6 kinase activity in Madin-Darby canine kidney renal epithelial cells. 1990 ·Journal of Biological Chemistry ·Kathryn E. Meier, James E. Weiel, Timothy J. Bloom, E G Krebs	16
14	Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. 1990 ·Proceedings of the National Academy of Sciences ·Michael F. Cicirelli, Nicholas K. Tonks, C D Diltz, James E. Weiel, Edmond H. Fischer, E G Krebs	133
15	Phorbol esters and calcium ionophore can prime murine peritoneal macrophages for tumor cell destruction. 1986 ·The Journal of Immunology ·Scott D. Somers, James E. Weiel, Thomas A. Hamilton, Dolph O. Adams	82
16	Expression of the transferrin receptor in murine peritoneal macrophages is modulated in the different stages of activation. 1984 ·The Journal of Immunology ·Thomas A. Hamilton, James E. Weiel, Dolph O. Adams	91
17	Murine monocytes express transferrin receptors: Evidence for similarity to inflammatory macrophages 1984 ·Cellular Immunology ·James E. Weiel, Dolph O. Adams, Thomas A. Hamilton	13
18	Quiescent lymphocytes express intracellular transferrin receptors 1984 ·Biochemical and Biophysical Research Communications ·James E. Weiel, Thomas A. Hamilton	20
19	Stabilizing effect of acetate salts and in digestors receiving high levels of glucose 1983 ·Canadian Journal of Microbiology ·John E. Robbins, (unknown), James E. Weiel, (unknown)	4
20	Down regulation of macrophage mannose/N-acetylglucosamine receptors by elevated glucose concnetrations 1983 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·James E. Weiel, (unknown)	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact